This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

It's On ... Again; HLTH and WebMD to Merge

Rather than have two publicly traded companies, HLTH (HLTH) and its subsidiary WebMD (WBMD - Get Report) decided to simplify.

This morning, HLTH and WebMD announced an agreement to merge in a tax-free, all-stock deal, with the surviving company being the more well known WebMD brand. WebMD is known for its trough of online health information.

At the beginning of 2008, the companies had agreed to a cash and stock merger, only to see the deal fall apart in the fall because because of the economic slowdown.

HLTH will get an aggregate ownership interest in the merged company that will roughly equal its current 80% interest in WebMD.

The deal will also knock out WebMD's dual-class stock structure, retiring WebMD's Class B shares -- of which HLTH owns 48.1 million shares. All outstanding shares of HLTH stock will convert into 0.4444 shares of WebMD's Class A stock. HLTH has 102.8 million shares of stock outstanding.

"Completion of this merger will significantly increase the liquidity of WebMD shares," Martin Wygod, acting CEO and Chairman of HLTH and Chairman of WebMD, said. "With a strong balance sheet and a simplified corporate structure, WebMD will be well positioned to deliver strong growth in the years ahead."
Copyright 2009 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WBMD $61.87 0.80%
HLTH $4.29 -3.40%
AAPL $92.24 -1.10%
FB $118.55 0.63%
GOOG $706.56 0.73%


Chart of I:DJI
DOW 17,638.22 -22.49 -0.13%
S&P 500 2,044.40 -6.23 -0.30%
NASDAQ 4,692.2070 -24.8870 -0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs